Impact of platelet transfusion on hematoma expansion in patients receiving antiplatelet agents before intracerebral hemorrhage

被引:56
|
作者
Ducruet, Andrew F. [1 ]
Hickman, Zachary L. [1 ]
Zacharia, Brad E. [1 ]
Grobelny, Bartosz T. [1 ]
DeRosa, Peter A. [1 ]
Landes, Elissa [1 ]
Lei, Shuang [1 ]
Khandji, Joyce [1 ]
Gutbrod, Sarah [1 ]
Connolly, E. Sander, Jr. [1 ]
机构
[1] Columbia Univ, Dept Neurol Surg, New York, NY 10032 USA
关键词
Antiplatelet agents; intracerebral hemorrhage; platelets; CEREBRAL-HEMORRHAGE; TIME-COURSE; ASPIRIN-USE; ENLARGEMENT; GROWTH; CLOPIDOGREL; INHIBITION; PREDICTORS; MORTALITY; THERAPY;
D O I
10.1179/174313209X459129
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: Patients receiving antiplatelet medications are reported to be at increased risk for hematoma enlargement and worse clinical outcomes following intracerebral hemorrhage (ICH). While platelet transfusions are frequently administered to counteract qualitative platelet defects in the setting of ICH, conclusive evidence in support of this therapeutic strategy is lacking. In fact, platelet transfusions may be associated with adverse effects, and represent a finite resource. We sought to determine the clinical efficacy of platelet transfusion and its impact on systemic complications following ICH in a cohort of patients receiving antiplatelet medications. Methods: We retrospectively analysed the medical records of 66 patients admitted to our institution from June 2003 to July 2008 who suffered a primary ICH while receiving antiplatelet (acetylsalicylic acid and/or clopidogrel) therapy. The primary outcome was the rate of significant (>25% increase from admission) hematoma expansion in transfused (n=535) versus non-transfused (n=531) patients. Discharge modified-Rankin score (mRS) and the rates of systemic complications were also assessed. Results: There were no statistically significant differences in rates of hematoma expansion between cohorts, nor were there differences in demographic variables, systemic complications or discharge mRS. Subgroup analysis revealed that there was a higher rate of hematoma expansion in the clopidogrel cohort (p=0.034) than in the cohort of patients receiving aspirin alone. Discussion: This study suggests that platelet administration does not reduce the frequency of hematoma expansion in ICH patients receiving antiplatelet medications. This lack of efficacy may relate to transfusion timing, as a significant proportion of hematoma expansion occurs within 6 hours post-ictus. Additionally, the increased rates of hematoma expansion in the clopidogrel cohort may relate to its prolonged half-life. A larger, prospective study is warranted.
引用
收藏
页码:706 / 710
页数:5
相关论文
共 50 条
  • [1] Early Administration of Desmopressin and Platelet Transfusion for Reducing Hematoma Expansion in Patients With Acute Antiplatelet Therapy Associated Intracerebral Hemorrhage*
    Mengel, Annerose
    Stefanou, Maria-Ioanna
    Hadaschik, Katharina Anna
    Wolf, Martin
    Stadler, Vera
    Poli, Khouloud
    Lindig, Tobias
    Ernemann, Ulrike
    Grimm, Florian
    Tatagiba, Marcos
    Ziemann, Ulf
    Poli, Sven
    [J]. CRITICAL CARE MEDICINE, 2020, 48 (07) : 1009 - 1017
  • [2] Impact of Platelet Transfusion on Intracerebral Hemorrhage in Patients on Antiplatelet Therapy-An Analysis Based on Intracerebral Hemorrhage Score
    Arnone, Gregory D.
    Kumar, Prateek
    Wonais, Matt C.
    Esfahani, Darian R.
    Campbell-Lee, Sally A.
    Charbel, Fady T.
    Amin-Hanjani, Sepideh
    Alaraj, Ali
    Seicean, Andreea
    Mehta, Ankit I.
    [J]. WORLD NEUROSURGERY, 2018, 111 : E895 - E904
  • [3] Role of Antiplatelet Agents in Hematoma Expansion During The Acute Period of Intracerebral Hemorrhage
    Michael Moussouttas
    Rishi Malhotra
    Luis Fernandez
    Mitchell Maltenfort
    Melissa Holowecki
    Jennifer Delgado
    Nadine Lawson
    Neeraj Badjatia
    [J]. Neurocritical Care, 2010, 12 : 24 - 29
  • [4] Role of Antiplatelet Agents in Hematoma Expansion During The Acute Period of Intracerebral Hemorrhage
    Moussouttas, Michael
    Malhotra, Rishi
    Fernandez, Luis
    Maltenfort, Mitchell
    Holowecki, Melissa
    Delgado, Jennifer
    Lawson, Nadine
    Badjatia, Neeraj
    [J]. NEUROCRITICAL CARE, 2010, 12 (01) : 24 - 29
  • [5] Previous Antiplatelet Use is Associated with Hematoma Expansion in Patients with Spontaneous Intracerebral Hemorrhage
    Yildiz, Ozlem Kayim
    Arsava, Ethem Murat
    Akpinar, Erhan
    Topcuoglu, Mehmet Akif
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2012, 21 (08): : 760 - 766
  • [6] Efficacy of platelet transfusion for acute intracerebral hemorrhage among patients on antiplatelet therapy
    Eke, Onyinyechi
    Shanechi, Mercedeh
    Gottlieb, Michael
    [J]. CANADIAN JOURNAL OF EMERGENCY MEDICINE, 2018, 20 : S78 - S81
  • [7] Platelet Transfusion After Traumatic Intracranial Hemorrhage in Patients on Antiplatelet Agents
    Lokhandwala, Adil M.
    Asmar, Samer
    Khurrum, Muhammad
    Chehab, Mohamad
    Bible, Letitia
    Castanon, Lourdes
    Ditillo, Michael
    Joseph, Bellal
    [J]. JOURNAL OF SURGICAL RESEARCH, 2021, 257 : 239 - 245
  • [8] Impact of Intraventricular Hemorrhage upon Intracerebral Hematoma Expansion
    Michael Moussouttas
    Rishi Malhotra
    Luis Fernandez
    Mitchell Maltenfort
    Melissa Holowecki
    Jennifer Delgado
    Nadine Lawson
    Neeraj Badjatia
    [J]. Neurocritical Care, 2011, 14 : 50 - 54
  • [9] Impact of Intraventricular Hemorrhage upon Intracerebral Hematoma Expansion
    Moussouttas, Michael
    Malhotra, Rishi
    Fernandez, Luis
    Maltenfort, Mitchell
    Holowecki, Melissa
    Delgado, Jennifer
    Lawson, Nadine
    Badjatia, Neeraj
    [J]. NEUROCRITICAL CARE, 2011, 14 (01) : 50 - 54
  • [10] Intraventricular Hemorrhage and Early Hematoma Expansion in Patients with Intracerebral Hemorrhage
    Li, Qi
    Huang, Yuan-Jun
    Zhang, Gang
    Lv, Fa-Jin
    Wei, Xiao
    Dong, Mei-Xue
    Chen, Jian-Jun
    Zhang, Li-Juan
    Qin, Xin-Yue
    Xie, Peng
    [J]. SCIENTIFIC REPORTS, 2015, 5